Ledger.Open graph →
SEC Form D · filed February 22, 2019

IMPEL NEUROPHARMA INC

Offering
$1.4M
Sold
—
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

John D. Hoekman · Seattle, WAExec · DirectorRobert D. Mittendorff · Seattle, WADirectorAli D. Satvat · Seattle, WADirectorAaron D. Royston · Seattle, WADirectorTim D. Nelson · Seattle, WADirectorMahendra D. Shah · Seattle, WADirectorJon D. Congleton · Seattle, WAExec · DirectorStewart D. Parker · Seattle, WADirectorBrian B. Miller · Chicago, ILDirectorMichael Ettling · Miami, FLDirectorAndrew Parker · Chicago, ILDirectorAnthony B. Davis · Chicago, ILDirectorThomas Ritter · Chicago, ILDirectorJocelyn White · London, United KingdomDirectorWilliam Toms · SAN FRANCISCO, CAExec · DirectorTerrence Schmid · SAN FRANCISCO, CAExec · DirectorJim D. Young · Seattle, WADirectorRaphael Schorr · Boston, MADirectorMichael Coe · Perry, KSDirectorJay Po · LINCOLN, MADirectorKarim Faris · Boston, MADirectorMegan A. Bailey · Baltimore, MDDirectorStephan Cubba · Detroit, MIExec · DirectorPing Wang · MOUNTAIN VIEW, CADirectorYanjuan Chen · MOUNTAIN VIEW, CAExec · DirectorJim D. Young · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗